# FDA Inspection 1122336 - Laboratorios Grifols S.A. - March 14, 2019

Source: https://www.keypedia.com/records/fda_inspections/laboratorios-grifols-sa/f6081e7b-9492-4b7c-8e63-ad03b51f7f8f
Source feed: FDA_Inspections

> FDA Inspection 1122336 for Laboratorios Grifols S.A. on March 14, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122336
- Company Name: Laboratorios Grifols S.A.
- Inspection Date: 2019-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1259883 - 2022-11-10](https://www.keypedia.com/records/fda_inspections/laboratorios-grifols-sa/371dd9d8-f4f1-47d7-8bb6-439646b20fd6)
- [FDA Inspection 933154 - 2015-06-05](https://www.keypedia.com/records/fda_inspections/laboratorios-grifols-sa/5fbe9c90-e622-4ffa-aea0-2ad426f1feb2)

Company: https://www.keypedia.com/companies/laboratorios-grifols-sa/286b8757-6830-49c3-add0-dd2346bdc165

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c